Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • lilduckdong lilduckdong Feb 15, 2013 9:17 PM Flag

    Why are many so-called 'analysts'

    focusing on Perifosine? I'd like to see progressive news on 108. That seems to be the real gem here. If the company gets a favorable independent review on Perifosine then just license it out again....this time to a bigger pharma and focus on 108.

 
AEZS
3.20+0.19(+6.31%)Jun 28 4:00 PMEDT